With a volatile market outlook, many investors are eyeing undervalued stocks that could offer strong potential for long-term growth. Recently,…
Biogen FDA Breakthrough Therapy Designation Biogen Inc. (Nasdaq: BIIB), a leading biotechnology company, announced today that its investigational anti-CD38 monoclonal…